Study on factors linked to death in severe tissue infections
Part of Bones, joints & muscles, Infections, Kidney & urinary clinical trials.
This study looks at what factors are linked to higher risk of death in patients hospitalized with a severe, flesh-eating infection called necrotizing soft tissue infection (NSTI). It aims to help doctors better identify and treat these dangerous infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must be admitted to the hospital with a diagnosis of a necrotizing (flesh-eating) soft tissue infection, such as necrotizing fasciitis, Fournier's gangrene, or similar infections in the neck or trunk
- You cannot have a non-necrotizing skin or soft tissue infection
- You must not be transferred to another hospital before your treatment is complete or before your outcome is known
- The study must have complete information about whether you survived or not during your hospital stay
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a rare but serious infection called necrotizing soft-tissue infection (NSTI), which destroys tissue quickly. It looks at how patients are treated in hospitals across Europe to improve care.
This trial tests a new way to quickly diagnose necrotizing soft tissue infections (NSTIs, also called flesh-eating infections) using a safe dye and a camera. If you are being checked for a possible NSTI, this could help doctors decide faster whether you have it and need treatment.
This trial is testing whether giving extra oxygen in a special chamber (hyperbaric oxygen therapy) can help treat a serious, deep-skin infection. You may qualify if you've been diagnosed with this infection and are well enough for surgery.
This study tests two special wound dressings (Cytal® Wound Matrix and MicroMatrix®) to help heal wounds caused by a serious flesh-eating infection called necrotizing fasciitis. The goal is to see if these dressings improve healing and reduce the need for more surgeries.
This study follows patients who have a serious infection of the skin and soft tissues (necrotizing soft-tissue infection) and are treated with a specific care plan called SURFAST. It aims to learn more about how this care approach works.
This study looks at people who had a bloodstream infection caused by a specific group of streptococcus bacteria (Streptococcus anginosus group). The goal is to understand what factors might be linked to death in these infections.
Hear when a new Necrotizing Fascitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.